2010
DOI: 10.1016/j.vetmic.2009.09.067
|View full text |Cite
|
Sign up to set email alerts
|

Molecular characterization of enrofloxacin resistant Actinobacillus pleuropneumoniae isolates

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

4
26
1
5

Year Published

2011
2011
2022
2022

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 41 publications
(36 citation statements)
references
References 20 publications
4
26
1
5
Order By: Relevance
“…All six isolates with an MIC ≥ 0.25 mg/L for enrofloxacin had an identical amino acid exchange (S83F) in the GyrA protein, which is in agreement with a previous study in A. pleuropneumoniae (Wang et al, 2010). Wang et al (2010) also reported that combinations of this and other mutations in gyrA, parC , and parE were associated with higher levels of resistance to enrofloxacin (MIC ≥ 1 mg/L), but these were not detected in our isolates.…”
Section: Discussionsupporting
confidence: 92%
See 1 more Smart Citation
“…All six isolates with an MIC ≥ 0.25 mg/L for enrofloxacin had an identical amino acid exchange (S83F) in the GyrA protein, which is in agreement with a previous study in A. pleuropneumoniae (Wang et al, 2010). Wang et al (2010) also reported that combinations of this and other mutations in gyrA, parC , and parE were associated with higher levels of resistance to enrofloxacin (MIC ≥ 1 mg/L), but these were not detected in our isolates.…”
Section: Discussionsupporting
confidence: 92%
“…Wang et al (2010) also reported that combinations of this and other mutations in gyrA, parC , and parE were associated with higher levels of resistance to enrofloxacin (MIC ≥ 1 mg/L), but these were not detected in our isolates. The six isolates with reduced susceptibility to enrofloxacin were isolated from samples submitted to the same APHA laboratory (Langford), and five were in the same year.…”
Section: Discussionmentioning
confidence: 49%
“…In the body of different species of animals enrofloxacin is subjected to metabolic transformation into ciprofloxacin, which chemotherapeutic activity is comparable to the maternal substance (Riddle et al 2000, Grobbel et al 2007). The mechanism of action of enrofloxacin consists of inhibition of bacterial DNA gyrase, which plays basic role in the process of DNA replication, leading to inhibition of synthesis of bacterial proteins (Vancutsem et al 1990, Wang et al 2010. The metabolism takes place in the liver through the N-oxidation, N-dealkylation and deethylation processes.…”
Section: Introductionmentioning
confidence: 99%
“…Cagliero et al (2007) selecionaram um mutante de C. jejuni multirresistente através do aumento das concentrações de enrofloxacina in vitro e afirmaram que a bomba de efluxo CmeABC tem relação com a resistência neste microrganismo. A resistência à ciprofloxacina conferida por bomba de efluxo também foi caracterizada em cepas de Actinobacillus pleuropneumoniae (Wang et al 2010).…”
Section: Discussionunclassified